云南高校图书馆联盟文献共享服务平台- RIFAXIMIN

RIFAXIMIN: 作品数：55被引量：289H指数：11; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：任淑萍陈瑞玲更多>>; 相关机构：首都医科大学附属北京天坛医院南昌大学更多>>; 相关期刊：《国外药讯》《World Journal of Hepatology》《Open Journal of Gastroenterology》《Current Medical Science》更多>>; 相关基金：国家自然科学基金更多>>

Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt:A meta-analysis: 《World Journal of Hepatology》2025年第4期120-136,共17页Xiao-Tong Xu Min-Jie Jiang Yun-Lai Fu Fang Xie Jian-Jun Li Qing-Hua Meng; BACKGROUND Hepatic encephalopathy(HE)is a primary complication following transjugular intrahepatic portosystemic shunt(TIPS),but the utility of pharmacological prophylaxis for HE is unclear.AIM To assess the HE incide...; 关键词：Transjugular intrahepatic portal shunt Hepatic encephalopathy CIRRHOSIS Prevention LACTULOSE RIFAXIMIN

Rifaximin-αuse is associated with improved muscle mass in patients with cirrhosis: 《World Journal of Hepatology》2025年第4期43-52,共10页Thomas Worland Penelope Hey Darren Wong Ross Apostolov Roseanne Kimberley Chan Marie Sinclair Paul Gow; Supported by Norgine,the marketing authorization holder of rifaximin-α(Xifaxan©).; BACKGROUND Sarcopaenia is associated with a two-fold higher mortality rate in patients with cirrhosis independent of liver disease severity.Few treatments for cirrhosis related sarcopaenia exist beyond optimal nutriti...; 关键词：RIFAXIMIN ENCEPHALOPATHY CIRRHOSIS Liver transplantation Sarcopaeni

Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy被引量：2: 《World Journal of Hepatology》2023年第11期1226-1236,共11页Jessica A Ward Jason Yerke Mollie Lumpkin Aanchal Kapoor Christina C Lindenmeyer Stephanie Bass; BACKGROUND Rifaximin is frequently administered to critically ill patients with liver disease and hepatic encephalopathy,but patients currently or recently treated with antibiotics were frequently excluded from studie...; 关键词：RIFAXIMIN Hepatic encephalopathy Critical illness ANTIBIOTICS Liver disease CIRRHOSIS

Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy被引量：1: 《World Journal of Gastroenterology》2023年第1期61-74,共14页Seohyuk Lee Saad Saffo; Cirrhosis is a leading cause of morbidity and mortality,impacting more than 120 million people worldwide.Although geographic differences exist,etiologic factors such as alcohol use disorder,chronic viral hepatitis inf...; 关键词：CIRRHOSIS Hepatic decompensation BETA-BLOCKERS STATINS Sodium-glucose cotransporter-2 inhibitors RIFAXIMIN

Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment被引量：2: 《World Journal of Hepatology》2022年第3期634-646,共13页Elina Manzhalii Valentyna Moyseyenko Vitalii Kondratiuk Nataliia Molochek Tetyana Falalyeyeva Nazarii Kobyliak; BACKGROUND Hepatic encephalopathy(HE)can be considered a result of dysregulated gutliver-brain axis function,where cognitive impairment can be reversed or prevented by the beneficial effects induced by"gut-centric"the...; 关键词：Hepatic encephalopathy Chronic liver disease CIRRHOSIS Gut microbiota E.coli Nissle 1917 Cognitive functions Stroop test RIFAXIMIN LACTULOSE

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care被引量：5: 《World Journal of Gastroenterology》2020年第18期2221-2231,共11页Anuj Bohra Thomas Worland Samuel Hui Ryma Terbah Ann Farrell Marcus Robertson; BACKGROUND Hepatic encephalopathy(HE)is a reversible neuropsychiatric complication of liver cirrhosis and occurs in up to 50%of cirrhotic patients.Studies examining the prognostic significance of HE are limited despit...; 关键词：Hepatic encephalopathy CIRRHOSIS Portal hypertension PROGNOSIS RIFAXIMIN LACTULOSE

Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study被引量：13: 《World Journal of Gastroenterology》2020年第2期199-218,共20页Xin-Yue Lv Hui-Guo Ding Jun-Fu Zheng Chun-Lei Fan Lei Li; Supported by the State Key Projects Specialized on Infectious Diseases,No.2017ZX10203202-004 and No.2017ZX10203202003008;the Digestive Medical Coordinated Development Centre of the Beijing Municipal Administration of Hospitals,No.XXZ0303;Beijing High-level Health Technicians,No.2013-03-073;Beijing Municipal Administration of Hospitals’Ascent Plan,No.DFL20151602; BACKGROUND Rifaximin has been shown to reduce the incidence of hepatic encephalopathy and other complications in patients with cirrhosis.However,few studies have investigated the effect of rifaximin in cirrhotic patie...; 关键词：RIFAXIMIN CIRRHOSIS Refractory ascites Inflammatory factors Gut microbiota Metagenomics sequencing

Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy被引量：3: 《World Journal of Hepatology》2020年第1期10-20,共11页Fiona Chautant Maeva Guillaume Marie-Angèle Robic Jean-François Cadranel Jean-Marie Peron Hortensia Lison Charlène Cool Christophe Bureau Véronique Duhalde; BACKGROUND Hepatic encephalopathy(HE)is a major complication of cirrhosis with independent prognostic significance.The current management of HE is mainly based on lactulose.Rifaximin has been shown to decrease the ris...; 关键词：RIFAXIMIN Hepatic encephalopathy CIRRHOSIS Liver disease HOSPITALIZATION

Current and future pharmacological therapies for managing cirrhosis and its complications被引量：21: 《World Journal of Gastroenterology》2019年第8期888-908,共21页David Kockerling Rooshi Nathwani Roberta Forlano Pinelopi Manousou Benjamin H Mullish Ameet Dhar; Supported by The Division of Integrative Systems Medicine and Digestive Disease at Imperial College London receives financial support from the National Institute for Health Research(NIHR)Imperial Biomedical Research Centre(BRC)based at Imperial College Healthcare NHS Trust and Imperial College London;funded by the NIHR BRC; Due to the restrictions of liver transplantation,complication-guided pharmacological therapy has become the mainstay of long-term management of cirrhosis.This article aims to provide a complete overview of pharmacothe...; 关键词：CIRRHOSIS BETA-BLOCKERS RIFAXIMIN DIURETICS STATINS Proton pump inhibitors Pharmacology

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options被引量：19: 《Journal of Clinical and Translational Hepatology》2017年第2期142-151,共10页Saleh Elwir Robert S.Rahimi; Hepatic encephalopathy is a spectrum of reversible neuropsychiatric abnormalities,seen in patients with liver dysfunction and/or portosystemic shunting.One of the most debilitating complications of cirrhosis,encephalo...; 关键词：Hepatic encephalopathy CIRRHOSIS LACTULOSE RIFAXIMIN

RIFAXIMIN